THDB0206

THDB0206 · Tonghua Dongbao Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for THDB0206, covering 2025-12-02 to 2025-12-22. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of THDB0206 Compared to Insulin Lispro Injection in Participants With Type 2 Diabetes [Phase 3]

See pricing